Skip to main content

Medtronic plc stock price and financials

  • MDT · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$102.86+1.85%Close 13 Nov 2026 · Next results 24 Nov 2026
EV / EBITDA
15.59
Beta · 1 year
0.14
Return · 1 year
+7.4%
52-week range$73.31 — $106.33

Share price close 16 Nov 2026

+8.1%1 monthHigh $104.96Low $92.77
$90$95$100$10523 Oct29 Oct4 Nov10 Nov16 Nov
+35.4%6 monthsHigh $104.96Low $73.75
$70$80$90$100$110Q4 FY2026 report filed 18 Jun 2026Q1 FY2027 report filed 3 Sep 20264 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
+7.4%year to dateHigh $104.96Low $73.75
$70$80$90$100$110Q3 FY2026 report filed 24 Feb 2026Q4 FY2026 report filed 18 Jun 2026Q1 FY2027 report filed 3 Sep 202611 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
+7.6%1 yearHigh $105.35Low $73.75
$70$80$90$100$110Q2 FY2026 report filed 25 Nov 2025Q3 FY2026 report filed 24 Feb 2026Q4 FY2026 report filed 18 Jun 2026Q1 FY2027 report filed 3 Sep 2026Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
+39.3%3 yearsHigh $105.35Low $73.75
$70$80$90$100$110Q2 FY2024 report filed 30 Nov 2023Q3 FY2024 report filed 27 Feb 2024Q4 FY2024 report filed 20 Jun 2024Q1 FY2025 report filed 27 Aug 2024Q2 FY2025 report filed 26 Nov 2024Q3 FY2025 report filed 25 Feb 2025Q4 FY2025 report filed 20 Jun 2025Q1 FY2026 report filed 26 Aug 2025Q2 FY2026 report filed 25 Nov 2025Q3 FY2026 report filed 24 Feb 2026Q4 FY2026 report filed 18 Jun 2026Q1 FY2027 report filed 3 Sep 2026Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+27.4%10 yearsHigh $134.63Low $69.43
$60$80$100$120$140Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26

Quarterly or annual report filed

In one paragraph

Medtronic plc reported revenue of $36.4 billion for fiscal year 2026 (the twelve months to 24 Apr 2026), up 8.4% from fiscal 2025. Net income was $4.80 billion and diluted earnings per share $3.73.

In its latest reported quarter, the first quarter of fiscal 2027 (the three months to 31 Jul 2026), revenue was $9.76 billion, up 13.7% from a year earlier.

Figures from Medtronic plc's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 3 Sep 2026.

Revenue FY2026
$36.36B+8.4%
Net income
$4.80B+3.0%
Diluted EPS
$3.73+3.3%
Gross margin
65.0%−0.3 pts
Free cash flow
$5.43B+4.6%
Net debt
$19.93B−3.5%

Fiscal 2026 against fiscal 2025; bars show the last 10 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.

Revenue and net income fiscal 2017–2026

  • Revenue
  • Net income
$0$10B$20B$30B$40BRevenue, FY17: $29.71BNet income, FY17: $4.03BFY17Revenue, FY18: $29.95BNet income, FY18: $3.1BFY18Revenue, FY19: $30.56BNet income, FY19: $4.63BFY19Revenue, FY20: $28.91BNet income, FY20: $4.79BFY20Revenue, FY21: $30.12BNet income, FY21: $3.61BFY21Revenue, FY22: $31.69BNet income, FY22: $5.04BFY22Revenue, FY23: $31.23BNet income, FY23: $3.76BFY23Revenue, FY24: $32.36BNet income, FY24: $3.68BFY24Revenue, FY25: $33.54BNet income, FY25: $4.66BFY25Revenue, FY26: $36.36BNet income, FY26: $4.8BFY26

Latest quarter · Q1 FY2027 to 31 Jul 2026, filed 3 Sep 2026 · Full results →

Revenue
$9.76B+13.7% on a year
Gross margin
65.0%0.0 pts on a year
Operating income
$1.76B+22.1% on a year
Net income
$1.47B+41.3% on a year
Diluted EPS
$1.14+40.7% on a year
Free cash flow
$1.29B+121% on a year

Comparable companies All of Health Care →

Medtronic plc beside the other S&P 500 members in Health Care Equipment, by market value.

Medtronic plc and comparable companies
CompanyMarket valueDay1 yearRevenue growthNet marginP/E
MedtronicMDT—+1.9%+7.4%———
Abbott LaboratoriesABT$188.1B+1.2%−15.8%+10.0%9.7%40.0
Intuitive SurgicalISRG$152.6B+0.8%−22.5%+20.5%25.5%51.6
Boston ScientificBSX$63.86B+0.3%−57.4%+8.9%16.6%18.2
Edwards LifesciencesEW$61.47B+1.3%+25.2%+13.4%15.3%60.2
Becton DickinsonBDX$59.14B+1.1%+44.4%−2.6%4.5%62.9
Idexx LaboratoriesIDXX$55.78B+0.9%−1.3%+11.9%25.4%47.2

Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.

Margins fiscal 2017–2026

  • Gross
  • Operating
  • Net
0%25%50%75%65.0%17.8%13.2%FY17FY20FY23FY26

Medtronic plc revenue by segment, product and region

Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.

By segment

Medtronic plc revenue by segment, by fiscal year
RevenueFY 2022FY 2023FY 2024FY 2025FY 2026
Cardiovascular$11.37B$11.52B+1.4%$11.83B+2.7%$12.48B+5.5%$13.98B+12.0%
Neuroscience$8.78B$8.96B+2.0%$9.41B+5.0%$9.85B+4.7%$10.29B+4.5%
Medical Surgical$8.47B$7.99B−5.7%$8.42B+5.4%$8.41B−0.1%$8.81B+4.9%
Other Operating Segments, Including Diabetes————$3.25B
Other operating segment, misc$727.0M$495.0M−31.9%$221.0M−55.4%$137.0M−38.0%$135.0M−1.5%
Not allocated to a line———−$89.00M−$96.00M
Total revenue$31.69B$31.23B$32.36B$33.54B$36.36B

By region

Medtronic plc revenue by region, by fiscal year
RevenueFY 2022FY 2023FY 2024FY 2025FY 2026
Rest of world$15.45B$14.76B−4.5%$15.69B+6.3%$16.25B+3.6%$18.12B+11.5%
United States$16.14B$16.37B+1.5%$16.56B+1.2%$17.17B+3.7%$18.10B+5.4%
Ireland$101.0M$98.00M−3.0%$113.0M+15.3%$116.0M+2.7%$143.0M+23.3%
Total revenue$31.69B$31.23B$32.36B$33.54B$36.36B

Financial statements

Fiscal years, the latest ending 24 Apr 2026. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.

Income statement

Medtronic plc income statement, annual
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Revenue$29.71B$29.95B$30.56B$28.91B$30.12B$31.69B$31.23B$32.36B$33.54B$36.36B
Revenue growth+3.0%+0.8%+2.0%−5.4%+4.2%+5.2%−1.4%+3.6%+3.6%+8.4%
Gross profit$20.42B$20.90B$21.40B$19.49B$19.63B$21.54B$20.51B$21.15B$21.91B$23.64B
Operating income$5.38B$6.64B$6.27B$4.79B$4.48B$5.75B$5.49B$5.14B$5.96B$6.47B
Net income$4.03B$3.10B$4.63B$4.79B$3.61B$5.04B$3.76B$3.68B$4.66B$4.80B
Diluted EPS$2.89$2.27$3.41$3.54$2.66$3.73$2.82$2.76$3.61$3.73
Gross margin68.7%69.8%70.0%67.4%65.2%68.0%65.7%65.3%65.3%65.0%
Operating margin18.1%22.2%20.5%16.6%14.9%18.2%17.6%15.9%17.8%17.8%
Net margin13.6%10.4%15.2%16.6%12.0%15.9%12.0%11.4%13.9%13.2%

Cash flow

Medtronic plc cash flow, annual
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Operating cash flow$6.88B$4.68B$7.01B$7.23B$6.24B$7.35B$6.04B$6.79B$7.04B$7.33B
Capital expenditure$1.25B$1.07B$1.13B$1.21B$1.35B$1.37B$1.46B$1.59B$1.86B$1.90B
Free cash flow$5.63B$3.62B$5.87B$6.02B$4.88B$5.98B$4.58B$5.20B$5.18B$5.43B

Balance sheet and shares

Medtronic plc balance sheet and shares, annual
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Cash and equivalents$4.97B$3.67B$4.39B$4.14B$3.59B$3.71B$1.54B$1.28B$2.22B$1.95B
Total debt$33.37B$25.75B$25.39B$25.86B$27.40B$24.98B$25.41B$26.05B$29.63B$29.15B
Shareholders' equity$50.21B$50.72B$50.09B$50.74B$51.43B$52.55B$51.48B$50.21B$48.02B$49.46B
Diluted shares1.4B1.4B1.4B1.4B1.4B1.4B1.3B1.3B1.3B1.3B
Dividends per share$1.72$1.84$2.00$2.16$2.32$2.52$2.72$2.76$2.80$2.84

Quarterly figures

The last eight fiscal quarters, the latest ending 31 Jul 2026. Year-on-year growth compares the same quarter of the previous fiscal year.

Medtronic plc quarterly financial figures
PeriodQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue$8.40B$8.29B$8.93B$8.58B$8.96B$9.02B$9.81B$9.76B
Revenue, year on year+5.2%+2.5%+3.9%+8.4%+6.6%+8.7%+9.9%+13.7%
Gross margin64.9%66.5%64.7%65.0%65.8%63.8%65.4%65.0%
Operating income$1.59B$1.65B$1.44B$1.45B$1.69B$1.46B$1.87B$1.76B
Net income$1.27B$1.29B$1.06B$1.04B$1.37B$1.14B$1.24B$1.47B
Diluted EPS$0.99$1.01$0.82$0.81$1.07$0.89$0.97$1.14
Free cash flow$554.0M$2.10B$2.07B$584.0M$457.0M$2.30B$2.08B$1.29B

Operating KPIs

The operating figures Medtronic plc reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.

Medtronic plc operating KPIs
KPILatestPeriodChange on a yearRecent periods
Electrophysiology Therapies revenue$2.2Bquarter to 31 Jul 2026up 29.6%
Surgical & Endoscopy revenue$1.7Bquarter to 31 Jul 2026up 8.7%
Cranial & Spinal Technologies revenue$1.4Bquarter to 31 Jul 2026up 12.7%
Structural Heart & Aortic revenue$1.0Bquarter to 24 Apr 2026up 6.3%
Specialty Therapies revenue$774.0Mquarter to 31 Jul 2026up 10.3%
Coronary & Peripheral Vascular revenue$685.0Mquarter to 24 Apr 2026up 3.9%
Acute Care & Monitoring revenue$539.0Mquarter to 31 Jul 2026up 14.4%
Neuromodulation revenue$539.0Mquarter to 31 Jul 2026up 4.9%
Reportable segment net sales$8.9Bquarter to 31 Jul 2026up 14.1%
Cardiovascular revenue$3.9Bquarter to 31 Jul 2026up 19.5%
Neuroscience revenue$2.7Bquarter to 31 Jul 2026up 10.3%
Medical Surgical revenue$2.3Bquarter to 31 Jul 2026up 9.9%
Diabetes revenue$843.0Mquarter to 31 Jul 2026up 16.9%
United States revenue$4.9Bquarter to 31 Jul 2026up 16.1%
International revenue$4.9Bquarter to 31 Jul 2026up 11.4%
Rest of world revenue$4.8Bquarter to 31 Jul 2026up 11.3%
Ireland revenue$40.0Mquarter to 31 Jul 2026up 21.2%

Method

Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.

The same figures as plain text and JSON.

Questions

What was Medtronic plc's revenue in fiscal 2026?

$36.4 billion for fiscal year 2026 (the twelve months to 24 Apr 2026), as reported in its annual report.

What was Medtronic plc's net income in fiscal 2026?

$4.80 billion for fiscal year 2026 (the twelve months to 24 Apr 2026).

What were Medtronic plc's diluted earnings per share in fiscal 2026?

$3.73 for fiscal year 2026 (the twelve months to 24 Apr 2026).

What is Medtronic plc's gross margin?

65.0% for fiscal year 2026 (the twelve months to 24 Apr 2026): gross profit divided by revenue.

What is Medtronic plc's operating margin?

17.8% for fiscal year 2026 (the twelve months to 24 Apr 2026): operating income divided by revenue.

How much free cash flow did Medtronic plc generate in fiscal 2026?

$5.43 billion for fiscal year 2026 (the twelve months to 24 Apr 2026): operating cash flow less capital expenditure.

Where does Medtronic plc's revenue come from?

In fiscal 2026, by region: Rest of world $18.12B (50%), United States $18.10B (50%), Ireland $143.0M (0.4%), out of $36.36B in all, as stated in its annual report.

In the terminal

Twenty years of Medtronic plc's figures, KPIs, guidance and a cash-flow valuation.

  • Every report line and operating figure, quarter by quarter
  • Guidance against what was delivered
  • Insider trades and institutional holders
  • Alerts on results, filings and price
See plans